Primary record
Alprostadil; 7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
- 库存
- 5,576 克
- 纯度
- 99.4 %
- CAS
- 745-65-3
化合物标识与属性
- CAS
- 745-65-3
- PubChem CID
- 5280723
- SMILES
- CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O
- Canonical SMILES
- CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O
名称与同义词
- alprostadil
- Prostaglandin E1
- Edex
- Caverject
- Muse
- PGE1
- Prostavasin
- Prostandin
- Alprostadilum
- Vasaprostan
- Prostin VR
- Topiglan
- 745-65-3
- Befar
- Liprostin
- Femprox
- Minprog
- Vitaros
- Prink
- Lipoprost
- Prostivas
- Sugiran
- Viridal
- l-Prostaglandin E1
- Alprox-TD
- Prostin VR Pediatric
- Promostan
- Prostin
- Alista
- Liple
- Palux
- Caverject Impulse
- FemLife
- PGE1alpha
- ProstaglandinE1
- RayVa
- Prostaglandine E
- Alprostan
- Alyprost
- Caveject
- Eglandin
- Prostine VR
- Viridal duo
- PGE1 Oligomer
- l-PGE1
- Lipo-alprostadil
- Alprostadil RS
- Caverject (TN)
- Lipo PGE1
- Alprostadil CRS
- SEPA-alprostadil
- (-)-Prostaglandin E1
- Prostaglandin K1
- Alprox TD
- Alprostadil(usan)
- PGE-1
- Viridal 5
- Lipo-PGE1
- Befar (TN)
- Prink (TN)
- Prostaglandin E1alpha
- Prostandin 500
- Alprostadil(Caverject)
- Viridal 10
- Viridal 20
- Edex (TN)
- Muse (TN)
- Lipoprostaglandin E1
- 1-Prostaglandin E1
- (-)-Protaglandin E1
- AC1NQXHQ
- SEPA-prostaglandin E1
- CHEMBL495
- PGE1;Prostaglandin E1
- RefChem:56455
- Alprostadilum [INN-Latin]
- DTXSID9022578
- SEPA-PGE1
- Prostin VR pediatric (TN)
- Prestwick2_001018
- Prestwick3_001018
- ALPROSTADIL [INN]
- ALPROSTADIL [JAN]
- Alprostadil Prostoglandin E1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N
- ALPROSTADIL [USAN]
- D0I4DQ
- D0N2EF
- ALPROSTADIL [VANDF]
- Alprostadil [EP monograph]
- PGE1 (Prostaglandin E1)
- BML1-F06
- DTXCID502578
- ALPROSTADIL [MART.]
- MFCD00077860
- SCHEMBL33317
- ALPROSTADIL [USP-RS]
- ALPROSTADIL [WHO-DD]
- BSPBio_001175
- BSPBio_001488
- UNII-F5TD010360
- CHEBI:15544
- MLS000758964
- MLS001424250
- ONO 1608
- Alprostadil (ProstaglandinE1)
- Alprostadil; Prostaglandin E1
- BIDD:GT0747
- HEI-507
- MR-256
- PROSTAGLANDIN E1 [MI]
- 1-PGE1
- BPBio1_001293
- GTPL1882
- orb1307980
- Alprostadil (JP15/USP/INN)
- Alprostadil (JP18/USP/INN)
- C20H34O5
- F5TD010360
- NSC 165559
- ONO-1608
- EINECS 212-017-2
- ALPROSTADIL [ORANGE BOOK]
- C01EA01
- G04BE01
- PGE1, Prostaglandin E1, powder
- SYN3025
- MR 256
- ALPROSTADIL [USP IMPURITY]
- GLXC-20048
- HMS1361K10
- HMS1571K17
- HMS1791K10
- HMS1989K10
- HMS2052L11
- HMS2090L08
- HMS2098K17
- HMS3268I09
- HMS3402K10
- HMS3414N09
- HMS3648O17
- HMS3678N07
- HMS3715K17
- (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid
- ALPROSTADIL [USP MONOGRAPH]
- NSC-165559
- Alprostadil [USAN:BAN:INN:JAN]
- Alprostadil [USAN:INN:BAN:JAN]
- AMY30076
- BCP01740
- EX-A1411
- HY-B0131
- MSK10682
- ZINC3813088
- Alprostadil [USAN:USP:INN:BAN:JAN]
- Tox21_110482
- U-10136
- (C20-H34-O5)x-
- 11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid
- BDBM50101853
- EBC-26712
- LMFA03010134
- NSC165559
- s1508
- 9-oxo-11R,15S-dihydroxy-13E-prostaenoic acid
- AKOS015961103
- (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
- AC-6095
- ACN-036193
- AI3-62116
- BCP9000277
- C20-H34-O5
- CCG-101188
- CID5280723
- CS-1905
- DB00770
- FA31828
- J3.319G
- NC00438
- RP17688
- CID:5280723
- IDI1_033958
- SMP2_000271
- U-10,136
- NCGC00016535-01
- NCGC00016535-19
- NCGC00025234-02
- NCGC00025234-03
- NCGC00025234-04
- NCGC00025234-05
- AS-16360
- BC205461
- CAS-745-65-3
- CPD000112594
- K274
- Prostaglandin E1, PGE1, 745-65-3
- SAM001246840
- SAM001246845
- SAM001247093
- SID:53790811
- SMR000112594
- U 10136
- 7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid
- Alprostadil 100 microg/mL in Acetonitrile
- (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid
- AB0014134
- AB2000131
- Muse (intraurethral alprostadil suppository)
- 11,15-Dihydroxy-9-oxoprost-13-en-1-oate
- AB00514004
- B2154
- NS00009541
- P1917
- ST50826271
- Alprostadil, meets USP testing specifications
- A11820
- C04741
- C76381
- D00180
- Prostaglandin E1, >=98% (HPLC), synthetic
- Prostaglandin E1;Edex;Muse;Liprostin;Caverject
- 11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
- AB00514004-06
- AB00514004-08
- AB00514004_09
- 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
- 745P653
- A838163
- D000527
- EN300-22411483
- Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-
- Q579348
- SR-01000597593
- SR-01000946253
- SR-01000597593-1
- SR-01000597593-5
- SR-01000597593-6
- SR-01000946253-1
- BRD-K52459643-001-06-0
- BRD-K52459643-001-10-2
- BRD-K52459643-001-15-1
- BRD-K52459643-001-17-7
- (13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoate
- (13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoic acid
- 11alpha,15(S)-Dihydroxy-9-oxo-13-trans-prostenoic acid
- 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid
- Alprostadil, European Pharmacopoeia (EP) Reference Standard
- B0084-299024
- l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid
- (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoate
- (13e)-(15s)-11alpha,15-dihydroxy-9-oxoprost-13-enoic acid
- Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)-
- Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11.alpha.,13E,15S)-
- (11?,13E,15S)-11,15-Dihydroxy-9-oxo-prost-13-en-1-oic acid
- (11|_,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
- (11|A,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
- (11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
- (11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid
- (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoic acid
- (1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid
- 11,15-dihydroxy-9-oxoprost-13-en-1-oic acid (ACD/Name 4.0)
- 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
- 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
- 7-[(1r,3r)-3-Hydroxy-2-[(1e,3s)-3-Hydroxyoct-1-En-1-Yl]-5-Oxocyclopentyl]heptanoic Acid
- Alprostadil, United States Pharmacopeia (USP) Reference Standard
- (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate
- (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid
- (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate
- (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid
- (11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
- (11alpha,12alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid
- (8R,13E,15S)-11alpha,15-Dihydroxy-9-oxoprosta-13-ene-1-oic acid
- 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclop entaneheptanoic acid
- 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid
- Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, ()-
- Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l-
- Cyclopentaneheptanoic acid, 3alpha-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-
- PGE1; Alprostadil; 9-oxo-11|A,15S-dihydroxy-prost-13E-en-1-oic acid
- Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11?,13E,15S)-
- Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11a,13E,15S)-
- Prostaglandin E1, synthetic, powder, BioReagent, suitable for cell culture
- (1R,2R,3R)-3-Hydroxy-2-[(E)-(3S)-3-hydroxy-1-octenyl]-5-oxocyclopentaneheptanoic acid
- (1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxy-1-octenyl]-5-oxocyclopentaneheptanoic acid
- 7-((1R,2R,3R)-3-hydroxy-2-((E,3S)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid
- 7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid
- 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]heptanoic acid
- Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer
- Prostaglandin E1, powder, gamma-irradiated, BioXtra, suitable for cell culture
- (Z)-7-[(1r,2r,3r)-3-Hydroxy-2-[(E,3s)-3-Hydroxyoct-1-Enyl]-5-Oxo-Cyclopentyl]hept-5-Enoic Acid
- 119314-69-1
- 212-017-2
- 7-((1R,2R,3R)-3-Hydroxy-2-((1E,3S)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid
- 7-[5-((1E)(3S)-3-hydroxyoct-1-enyl)(1R,4R,5R)-4-hydroxy-2-oxocyclopentyl]hepta noic acid
- Alprostadil; 7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
- P2E
- XPG